全文获取类型
收费全文 | 1360550篇 |
免费 | 116360篇 |
国内免费 | 6402篇 |
专业分类
耳鼻咽喉 | 17127篇 |
儿科学 | 43986篇 |
妇产科学 | 37374篇 |
基础医学 | 187010篇 |
口腔科学 | 36923篇 |
临床医学 | 122888篇 |
内科学 | 283829篇 |
皮肤病学 | 32409篇 |
神经病学 | 112952篇 |
特种医学 | 56235篇 |
外国民族医学 | 277篇 |
外科学 | 213279篇 |
综合类 | 31951篇 |
现状与发展 | 2篇 |
一般理论 | 455篇 |
预防医学 | 108443篇 |
眼科学 | 28598篇 |
药学 | 95051篇 |
5篇 | |
中国医学 | 2235篇 |
肿瘤学 | 72283篇 |
出版年
2018年 | 13767篇 |
2017年 | 10924篇 |
2016年 | 13098篇 |
2015年 | 14639篇 |
2014年 | 20466篇 |
2013年 | 30536篇 |
2012年 | 37296篇 |
2011年 | 40003篇 |
2010年 | 25030篇 |
2009年 | 24450篇 |
2008年 | 37366篇 |
2007年 | 39847篇 |
2006年 | 40960篇 |
2005年 | 39473篇 |
2004年 | 37759篇 |
2003年 | 36756篇 |
2002年 | 34811篇 |
2001年 | 66762篇 |
2000年 | 68679篇 |
1999年 | 57213篇 |
1998年 | 17012篇 |
1997年 | 15243篇 |
1996年 | 16250篇 |
1995年 | 16453篇 |
1994年 | 15298篇 |
1993年 | 14368篇 |
1992年 | 47662篇 |
1991年 | 46287篇 |
1990年 | 44439篇 |
1989年 | 42301篇 |
1988年 | 39224篇 |
1987年 | 38547篇 |
1986年 | 36283篇 |
1985年 | 35095篇 |
1984年 | 26717篇 |
1983年 | 22425篇 |
1982年 | 14060篇 |
1981年 | 12625篇 |
1980年 | 11922篇 |
1979年 | 23899篇 |
1978年 | 17310篇 |
1977年 | 14579篇 |
1976年 | 13396篇 |
1975年 | 13912篇 |
1974年 | 16318篇 |
1973年 | 15634篇 |
1972年 | 14389篇 |
1971年 | 13236篇 |
1970年 | 12060篇 |
1969年 | 11248篇 |
排序方式: 共有10000条查询结果,搜索用时 0 毫秒
991.
992.
J.-P. Ortonne A. Taïeb A.D. Ormerod† D. Robertson‡ J. Foehl‡ R. Pedersen‡ C. Molta‡ B. Freundlich‡ 《The British journal of dermatology》2009,161(5):1190-1195
Background Patients with psoriasis experience remission and gradual reappearance of erythematous and scaly plaques and require individualized treatment over time. A goal of psoriasis treatment is to provide optimal efficacy with a flexible therapeutic regimen that may include treatment pauses.
Objectives To determine whether patients receiving initial treatment with etanercept who then pause therapy would subsequently recapture response during re-treatment.
Patients and methods A post-hoc analysis of 226 patients with moderate-to-severe psoriasis from a large multicentre trial was performed. Patients had received etanercept 50 mg twice weekly subcutaneously until a target clinical response had been achieved, then had paused treatment and eventually relapsed. They were then re-treated with etanercept 25 mg twice weekly. The number of patients recapturing a Physician Global Assessment (PGA) of psoriasis rating of ≤ 2 (clear, almost clear or mild) on first re-treatment was assessed. Patient satisfaction during the initial treatment and first re-treatment period was also determined.
Results A total of 187 (83%) patients recaptured the target clinical response of a PGA of ≤ 2 after re-treatment. The majority of patients [219 of 226 (97%)] reported satisfaction with etanercept re-treatment. No new safety concerns emerged during re-treatment.
Conclusions In this post-hoc analysis, patients with psoriasis who were re-treated with etanercept 25 mg twice weekly effectively recaptured clinical responses that patients found satisfactory. A flexible treatment option is available to dermatologists and patients for individualized care. 相似文献
Objectives To determine whether patients receiving initial treatment with etanercept who then pause therapy would subsequently recapture response during re-treatment.
Patients and methods A post-hoc analysis of 226 patients with moderate-to-severe psoriasis from a large multicentre trial was performed. Patients had received etanercept 50 mg twice weekly subcutaneously until a target clinical response had been achieved, then had paused treatment and eventually relapsed. They were then re-treated with etanercept 25 mg twice weekly. The number of patients recapturing a Physician Global Assessment (PGA) of psoriasis rating of ≤ 2 (clear, almost clear or mild) on first re-treatment was assessed. Patient satisfaction during the initial treatment and first re-treatment period was also determined.
Results A total of 187 (83%) patients recaptured the target clinical response of a PGA of ≤ 2 after re-treatment. The majority of patients [219 of 226 (97%)] reported satisfaction with etanercept re-treatment. No new safety concerns emerged during re-treatment.
Conclusions In this post-hoc analysis, patients with psoriasis who were re-treated with etanercept 25 mg twice weekly effectively recaptured clinical responses that patients found satisfactory. A flexible treatment option is available to dermatologists and patients for individualized care. 相似文献
993.
L.A. Fischer T. Menné C. Avnstorp G.B. Kasting† J.D. Johansen† 《The British journal of dermatology》2009,161(3):560-567
Background Hydroxyisohexyl 3-cyclohexene carboxaldehyde (HICC) is a synthetic fragrance ingredient. Case reports of allergy to HICC appeared in the 1980s, and HICC has recently been included in the European baseline series. Human elicitation dose–response studies performed with different allergens have shown a significant relationship between the patch-test threshold and the repeated open application test (ROAT) threshold, which mimics some real-life exposure situations. Fragrance ingredients are special as significant amounts of allergen may evaporate from the skin.
Objectives The study aimed to investigate the relationship between elicitation threshold doses at the patch test and the ROAT, using HICC as the allergen. The expected evaporation rate was calculated.
Materials and methods Seventeen HICC-allergic persons were tested with a dilution series of HICC in a patch test and a ROAT (duration up to 21 days). Seventeen persons with no HICC allergy were included as control group for the ROAT.
Results The response frequency to the ROAT (in μg HICC cm−2 per application) was significantly higher than the response frequency to the patch test at one of the tested doses. Furthermore the response rate to the accumulated ROAT dose was significantly lower at half of the doses compared with the patch test. The evaporation rate of HICC was calculated to be 72% over a 24-h period.
Conclusions The ROAT threshold in dose per area per application is lower than the patch test threshold; furthermore the accumulated ROAT threshold is higher than the patch test threshold, which can probably be explained by the evaporation of HICC from the skin in the open test. 相似文献
Objectives The study aimed to investigate the relationship between elicitation threshold doses at the patch test and the ROAT, using HICC as the allergen. The expected evaporation rate was calculated.
Materials and methods Seventeen HICC-allergic persons were tested with a dilution series of HICC in a patch test and a ROAT (duration up to 21 days). Seventeen persons with no HICC allergy were included as control group for the ROAT.
Results The response frequency to the ROAT (in μg HICC cm
Conclusions The ROAT threshold in dose per area per application is lower than the patch test threshold; furthermore the accumulated ROAT threshold is higher than the patch test threshold, which can probably be explained by the evaporation of HICC from the skin in the open test. 相似文献
994.
995.
996.
997.
998.
Immigrants, and especially those recently arrived in host countries, are a high-risk group for tuberculosis. In 2006 in France, nearly half of the new cases of tuberculosis were reported in this group. The incidence rate among people born abroad was about seven times higher than that observed in people born in France (38.9/105 vs 5.2/105). The incidence was also the highest in districts with a high proportion of socioeconomically vulnerable population, such as Paris and greater Paris area. The characteristics of French born and non-French born cases differed. Patients born abroad were less likely to have pulmonary tuberculosis (68.2% vs 78.2; p < 0.001) and were more likely to live in institutions (such as migrant shelters) and to harbor multiresistant tuberculosis strains. A national tuberculosis control program was launched in France in 2007, to decrease the prevalence of tuberculosis in targeted populations. 相似文献
999.
Workplace status and risk of hypertension among hourly and salaried aluminum manufacturing employees
Jane Ellen Clougherty Ellen A. Eisen Martin D. Slade Ichiro Kawachi Mark R. Cullen 《Social science & medicine (1982)》2009
An inverse relationship between workplace status and morbidity is well established; higher job status has been associated with reduced risks of heart disease, hypertension, and injury. Most research on job status, however, has focused on salaried populations, and it remains unclear whether job status operates similarly among hourly workers. Our objectives were to examine whether hourly status itself influences risk of hypertension after adjustment for socioeconomic confounders, and to explore the role of fine-scale job grade on hypertension incidence within hourly and salaried groups. We examined data for 14,999 aluminum manufacturing employees in 11 plants across the U.S., using logistic regression with adjustment for age, sex, race/ethnicity and other individual characteristics. Propensity score restriction was used to identify comparable groups of hourly and salaried employees, reducing confounding by sociodemographic characteristics. Job grade (coded 1 through 30, within hourly and salaried groups) was examined as a more refined measure of job status. Hourly status was associated with an increased risk of hypertension, after propensity restriction and adjustment for confounders. The observed effect of hourly status was stronger among women, although the propensity-restricted cohort was disproportionately male (96%). Among salaried workers, higher job grade was not consistently associated with decreased risk; among hourly employees, however, there was a significant trend, with higher job grades more protective against hypertension. Increasing the stringency of hypertension case criteria also increased the risk of severe or persistent hypertension for hourly employees. 相似文献
1000.